Brief: Expres2ion Biotech Holding Q4 Operating Income Up At SEK 3.5 Mln
19/02/2026 07:50
Feb 19 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST: Q4 OPERATING INCOME: SEK 3,533 (2,178) THOUSAND Q4 PROFIT/LOSS AFTER FINANCIAL ITEMS: SEK -9,998 (-19,353) THOUSAND Source text: ID:nMFN63cDT3 Further company coverage: EXPRS2.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations